The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Brumm Joshua T since 2015.
This trader's CIK number is 1528826.
At the time of last reporting, Brumm Joshua T was the CEO & President of Dyne Therapeutics, Inc.. (stock ticker symbol DYN).
Also see all insider trading activities at Dyne Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | VSAR | 0 | $0 | 36,955 | $728,258 | 30,000 | $75,900 |
| 2016 | VSAR | 0 | $0 | 7,714 | $93,377 | 0 | $0 |
| 2015 | VSAR | 2,500 | $24,975 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | DYN | 0 | $0 | 808,535 | $19,547,224 | 783,062 | $3,614,527 |
| 2023 | DYN | 0 | $0 | 359,937 | $4,572,960 | 278,030 | $286,369 |
| 2022 | DYN | 0 | $0 | 213,384 | $2,659,064 | 210,000 | $216,300 |
| 2021 | DYN | 0 | $0 | 8,009 | $127,312 | 0 | $0 |
2. Dyne Therapeutics, Inc. (DYN)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-10-19 | VSAR | Sale | 1,326 | 2.55 | 3,381 |
| 2017-06-13 | VSAR | Sale | 1,421 | 16.05 | 22,807 |
| 2017-05-16 | VSAR | Sale | 1,263 | 17.40 | 21,976 |
| 2017-02-24 | VSAR | Option Ex | 30,000 | 2.53 | 75,900 |
| 2017-02-24 | VSAR | Sale | 30,000 | 21.31 | 639,300 |
| 2017-01-30 | VSAR | Sale | 2,945 | 13.85 | 40,794 |
| 2016-12-27 | VSAR | Sale | 990 | 15.85 | 15,691 |
| 2016-12-07 | VSAR | Sale | 3,021 | 13.25 | 40,028 |
| 2016-06-15 | VSAR | Sale | 1,448 | 10.63 | 15,392 |
| 2016-05-20 | VSAR | Sale | 1,265 | 7.87 | 9,955 |
| 2015-12-30 | VSAR | Sale | 990 | 12.44 | 12,311 |
| 2015-11-12 | VSAR | Buy | 2,500 | 9.99 | 24,975 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-03-08 | DYN | Sale | 363,343 | 26.47 | 9,616,599 |
| 2024-03-11 | DYN | Option Ex | 50,000 | 5.54 | 277,000 |
| 2024-03-11 | DYN | Sale | 66,387 | 25.89 | 1,718,958 |
| 2024-03-08 | DYN | Option Ex | 363,343 | 5.54 | 2,012,920 |
| 2024-03-07 | DYN | Sale | 9,086 | 25.85 | 234,873 |
| 2024-02-29 | DYN | Sale | 5,520 | 27.50 | 151,800 |
| 2024-03-01 | DYN | Sale | 94,480 | 29.06 | 2,745,588 |
| 2024-02-29 | DYN | Option Ex | 5,520 | 5.54 | 30,580 |
| 2024-03-01 | DYN | Option Ex | 94,480 | 5.54 | 523,419 |
| 2024-01-04 | DYN | Option Ex | 218,536 | 3.29 | 717,890 |
| 2024-01-03 | DYN | Option Ex | 51,183 | 1.03 | 52,718 |
| 2024-01-04 | DYN | Sale | 218,536 | 18.73 | 4,092,086 |
| 2024-01-03 | DYN | Sale | 51,183 | 19.29 | 987,320 |
| 2023-12-11 | DYN | Sale | 7,585 | 10.72 | 81,311 |
| 2023-09-18 | DYN | Sale | 12,032 | 9.41 | 113,221 |
| 2023-09-12 | DYN | Sale | 7,672 | 10.41 | 79,865 |
| 2023-06-08 | DYN | Option Ex | 30,088 | 1.03 | 30,990 |
| 2023-06-09 | DYN | Option Ex | 76,582 | 1.03 | 78,879 |
| 2023-06-08 | DYN | Sale | 61,000 | 13.31 | 811,910 |
| 2023-06-09 | DYN | Sale | 76,582 | 13.34 | 1,021,603 |
| 2023-06-12 | DYN | Option Ex | 171,360 | 1.03 | 176,500 |
| 2023-06-12 | DYN | Sale | 187,748 | 12.61 | 2,367,502 |
| 2023-03-14 | DYN | Sale | 7,318 | 13.33 | 97,548 |
| 2022-10-10 | DYN | Sale | 195,800 | 12.46 | 2,439,668 |
| 2022-10-07 | DYN | Option Ex | 14,200 | 1.03 | 14,626 |
| 2022-10-10 | DYN | Option Ex | 195,800 | 1.03 | 201,674 |
| 2022-10-07 | DYN | Sale | 14,200 | 13.37 | 189,854 |
| 2022-03-11 | DYN | Sale | 3,384 | 8.73 | 29,542 |
| 2021-09-20 | DYN | Sale | 3,425 | 15.61 | 53,464 |
| 2021-09-21 | DYN | Sale | 4,584 | 16.11 | 73,848 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Brumm Joshua T (CEO & President of Dyne Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.